The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling

Ji-Youn Lim1, Tae Joon Won, Bang Yeon Hwang

  • 1Graduate School of Medicine, Korea University, Seoul 136-701, Republic of Korea.

Insights

Isodojaponin D, a diterpene from Isodon japonicus, reduces neuroinflammation by inhibiting microglial activation. This compound suppressed pro-inflammatory mediators via the NF-kappaB and MAPK pathways, offering potential for neurodegenerative disease treatment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Neuroinflammation, driven by microglial activation, elevates pro-inflammatory mediators, leading to neuronal damage.
  • Suppression of neuroinflammation is a potential therapeutic strategy for neurodegenerative diseases.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of isodojaponin D on lipopolysaccharide (LPS)-induced microglial activation.
  • To elucidate the underlying mechanisms of isodojaponin D's anti-inflammatory action.

Main Methods:

  • BV2 microglial cells were treated with isodojaponin D prior to LPS stimulation.
  • RT-PCR and Western blot analyses were used to assess the expression of inflammatory markers.
  • NF-kappaB and MAPK signaling pathways were investigated.

Main Results:

  • Isodojaponin D significantly reduced LPS-induced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) production in a dose-dependent manner.
  • Pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha) were decreased by isodojaponin D.
  • Inhibition of NF-kappaB (p50, p65) nuclear translocation and IkappaB degradation, along with attenuated MAPK activation, was observed.

Conclusions:

  • Isodojaponin D suppresses LPS-induced microglial activation and pro-inflammatory mediator production.
  • The anti-inflammatory effects are mediated through the inhibition of NF-kappaB signaling and MAPK phosphorylation.
  • Isodojaponin D shows promise as a therapeutic agent for neurodegenerative diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...